Skip to main content

Table 4 PCE risk-specific dose calculations using WHO/IPCS 2017 workflow. The POD is 3.6 ppm (Echeverria et al., 1995)

From: Application of probabilistic methods to address variability and uncertainty in estimating risks for non-cancer health effects

Factor

Median (P50)a

Spread (P95/P50)a

Point of Departure

3.6 ppm

1.89a

Human Variabilityb

I=1%: 9.7

I=0.1%: 20.42

I=1%: 4.3

I=0.1%: 6.99

HD.051% (I=1%)c

3.6/(9.7) = 0.37 ppm

10[(log1.89)2 + (log4.3)2]1/2= 4.88

HD.051% (I=1%)c

(1-in-100, 95% conf)

0.37/4.88= 0.08 ppm

HD.050.1% (I=0.1%)c

3.6/(20.42)= 0.18 ppm

10[(log1.89)2 + (log6.99)2]1/2= 7.70

HD.050.1% (I-0.1%)c

(1-in-1000, 95% conf)

0.18/7.70 = 0.02 ppm

  1. P05 = 5th percentile of distribution; P50=50th percentile of distribution; P95=95th percentile of distribution
  2. aAssumes P05 = P50/[P95/P50]; 3.6/1.9 = 1.89
  3. bWHO/IPCS, 2017 Table 4.5
  4. cWHO/IPCS, 2017 Fig. 3.5c Approximate probabilistic analysis